http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021201092-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7d7f51b30ceeb9e2e0d55b74908ec06
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6837
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6837
filingDate 2021-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_49c691d67f77dcbadabf4e264e59e396
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c072bf2146e4b0f824be9819210af84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4846bbee83e3c6d4e29968fab1c250e2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d18a481be83d7cb429d97a1e344e270
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_468eecf63b8d7a0dd789e25b86f1c183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794c440fb03689df5effd709930759f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96b88307d35022fb90f262564658efc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b6f7ed654d42f6ea41ab5e59338505d
publicationDate 2021-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2021201092-A1
titleOfInvention Kit or device and method for detecting hippocampal atrophy
abstract The present invention relates to: a kit or device for detecting hippocampal atrophy, the kit or device including a nucleic acid capable of binding specifically to predetermined miRNA, which is a marker for hippocampal atrophy, or to a complementary strand thereof; and a method for detecting hippocampal atrophy, the method including measuring the miRNA in vitro.
priorityDate 2020-03-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019014457-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019048500-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019136320-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019004436-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018199275-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019249250-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017184642-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019159884-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014272993-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281670
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409598

Total number of triples: 37.